$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Ponesimod的用法用量?
2025-10-19 11:44:20
Check Details
既存心脏疾病患者使用Ponesimod过程中的注意事项?
2025-10-19 11:44:20
Check Details
Ponesimod会引发进行性多灶性白质脑病(PML)吗?
2025-10-19 11:44:20
Check Details
心脏病患者使用Ponesimod的注意事项?
2025-10-19 11:44:20
Check Details
Ponesimod有哪些规格?
2025-10-19 11:44:20
Check Details
使用Ponesimod需注意引发房室传导延迟的风险
2025-10-19 11:44:20
Check Details
多发性硬化症”特效药“Ponesimod|年复发率显著降低30.5%!
2025-10-19 11:44:20
Check Details
多发性硬化症特立氟胺给报销吗?
2025-10-19 11:44:20
Check Details
特立氟胺和西尼莫德片怎样选?
2025-10-19 11:44:20
Check Details
芬戈莫德是免疫抑制剂吗?
2025-10-19 11:44:20
Check Details
芬戈莫德的治疗效果
2025-10-19 11:44:20
Check Details
Ponesimod的治疗效果好吗
2025-10-19 11:44:20
Check Details
1
2
...
3283
3284
3285
3286
3287
3288
3289
...
10241
10242
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Key points for drug monitoring of Molotinib in bone marrow fibrosis
2
Elacestrant US Approval and Treatment Planning While Not Yet Available Locally
3
Stiripentol in Dravet Syndrome: Growth, Cognitive Development and Long-Term Follow-Up Management
4
FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor: Mechanism, Dosing and MANEUVER Data
5
Cabozantinib Overview: Multi-Target TKI Efficacy and Safety Monitoring for Bleeding, Hypertension, Thrombosis
6
FDA Approves Sunharbo (asundexian), the World’s First FXIa Inhibitor, to Reduce Stroke Risk in Adults with Recent Non‑Cardioembolic Ischemic Stroke or High‑Risk TIA
7
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
8
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring
9
Pirtobrutinib and Risks of Atrial Fibrillation and Bleeding: Mechanism, Data Interpretation and Monitoring
10
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
11
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
12
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL